结膜淋巴管扩张可作为Ser77Tyr遗传性转甲状腺素蛋白淀粉样变性严重系统性疾病的生物标志物
这项横断面研究纳入24例经基因确诊的ATTRS77Y淀粉样变性患者,评估眼部与全身表型的关系。结果显示54%患者存在结膜淋巴管扩张(CL),且CL与更严重的神经病变和淀粉样心肌病显著相关,提示CL可作为严重系统性疾病的潜在生物标志物。
要点
- ATTRS77Y患者中结膜淋巴管扩张常见,检出率为54%。
- 结膜淋巴管扩张与更严重的神经病变及淀粉样心肌病显著相关。
- ATTRS77Y患者未出现前房沉积、继发性青光眼或玻璃体淀粉样沉积。
核心结论
- 在ATTRS77Y患者中,结膜淋巴管扩张常见,可能作为严重系统性疾病的潜在生物标志物。
研究设计与样本
- 横断面研究,纳入24例经基因确诊的ATTRS77Y淀粉样变性患者,平均年龄58.4±12.4岁。
- 所有患者接受完整神经学检查(含NIS和PND评分)、心脏病学评估(含超声心动图、心脏MRI和/或心脏闪烁显像)及完整眼科检查(含裂隙灯和眼底检查)。
- 对眼部检查异常者行荧光素和吲哚菁绿血管造影及眼前段光学相干断层扫描。
- 定量结局采用Kruskal-Wallis检验,定性结局采用Fisher精确检验,p<0.05(双侧)为差异有统计学意义。
主要发现
- 13例患者(54%)检出结膜淋巴管扩张,伴有淋巴管周围淀粉样沉积。
- 4例患者观察到视网膜血管病变,其中1例并发视网膜缺血。
- 无患者出现前房淀粉样沉积、继发性青光眼或玻璃体淀粉样变性。
- 有结膜淋巴管扩张的患者神经病变更严重:NIS为43.3±31.9 vs 18.9±20.4,PND为2.6±1.0 vs 1.4±0.7(均有p<0.05)。
- 结膜淋巴管扩张与淀粉样心肌病显著相关(p=0.002)。
临床怎么用
- 对ATTRS77Y患者进行眼科裂隙灯检查时,应关注结膜淋巴管扩张,其出现提示需评估系统性疾病的严重程度。
- 结膜淋巴管扩张可作为识别ATTRS77Y患者中严重神经病变和淀粉样心肌病的潜在眼部标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To investigate the relationship between the ophthalmic and systemic phenotypes in patients with hereditary transthyretin amyloidosis with the S77Y mutation (ATTRS77Y). METHODS: In this cross-sectional study, patients with genetically confirmed ATTRS77Y amyloidosis were enrolled. All patients underwent complete neurological examination, including staging with the Neuropathy Impairment Score (NIS), Polyneuropathy Disability (PND) score; complete cardiological evaluation, including echocardiography, cardiac MRI and/or cardiac scintigraphy and complete ophthalmic evaluation, including slit lamp examination and fundus examination. Ocular ancillary tests (fluorescein and indocyanine green angiography, and anterior segment optical coherence tomography) were performed in cases with abnormal findings. The Kruskal-Wallis test was used for quantitative outcomes and Fisher's exact test for qualitative outcomes. Statistical significance was indicated by p<0.05 (two tailed). RESULTS: The study sample was composed of 24 ATTRS77Y patients. The mean patient age was 58.4±12.4 years. None of the patients presented with amyloid deposits in the anterior chamber, secondary glaucoma or vitreous amyloidosis. Retinal angiopathy was observed in four patients, complicated with retinal ischaemia in one patient. Conjunctival lymphangiectasia (CL) was detected in 13 patients (54%), associated with perilymphatic amyloid deposits. The presence of CL was statistically associated with more severe neurological disease (NIS=43.3±31.9 vs 18.9±20.4; PND=2.6±1.0 vs 1.4±0.7 in patients with and without CL, respectively; both p<0.05) and amyloid cardiomyopathy (p=0.002). CONCLUSION: In ATTRS77Y patients, CL is common and could serve as a potential biomarker for severe systemic disease. There were neither anterior chamber deposits, secondary glaucoma nor vitreous deposits in ATTRS77Y patients.
引用
- Bunod R, Adams D, Cauquil C, et al. Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis. Br J Ophthalmol. 2020. PMID: 31949094. doi:10.1136/bjophthalmol-2019-315381
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。